InvestorsHub Logo
Followers 827
Posts 119482
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Tuesday, 03/14/2023 4:36:23 PM

Tuesday, March 14, 2023 4:36:23 PM

Post# of 6723
ABUS presents preclinical data on COVID antiviral, AB-343 at ICAR:

https://www.globenewswire.com/news-release/2023/03/14/2627174/14025/en/Arbutus-Presents-AB-343-Data-at-the-36th-International-Conference-on-Antiviral-Research.html

ABUS is pretty far behind such players as ENTA and PRDS. AVIR is already in phase-3, but I think they have a bad drug.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News